 A slow week.  There is more concerning data regarding the use of marijuana in pregnant women, which is prevalent in pregnant teens.  And an elegant study from Peter Schmidt and David Rubinow which gives [...]
Over the years, we have seen a number of research studies which suggested a link between maternal smoking during pregnancy and adverse psychiatric outcomes in offspring, including increased risk for bipolar disorder, schizophrenia, and attention-deficit/hyperactivity [...]
Beta blockers are the most commonly used class of medication for treating cardiac conditions in pregnant women. Â They are also effective for the treatment of anxiety symptoms, most commonly performance anxiety. According to a report [...]
Pregabalin (marketed in the US as Lyrica) is approved by the US Food and Drug Administration for the treatment of epilepsy, fibromyalgia, and neuropathic pain. Â It is also used off-label to treat psychiatric disorders, most [...]
The two lead articles take a look at the use of two anticonvulsants during pregnancy, lamotrigine (Lamictal) and pregabalin (Lyrica); the data are reassuring with regard to the reproductive safety of these medications. Pariente G, [...]
 At the top of the list are three articles (and one commentary) looking at the risk of autism in children exposed to SSRIs. We will soon cover these reports in greater detail; however, the [...]
Over the last few years, we have seen a number of articles suggesting that the burden of menopausal symptoms is probably greater than generally perceived.  About 80% of women experience vasomotor symptoms (VMS) – hot [...]
 The first article on the list from Andrade is an excellent discussion of the difficulties in assessing outcomes in studies of antidepressants during pregnancy.  In addition, there are two articles, one from Vigod and [...]
 While we know that PTSD is about twice as common in women as men, most PTSD research has focused on PTSD in men, most commonly male veterans.  A recent study, reviewed in Medscape, evaluated [...]
 Previous studies have indicated that depression during the perimenopausal transition is associated with various risk factors, including previous history of depression, poor physical health, and more severe perimenopausal symptoms.  A recent study (reviewed here) [...]
